FDA Approved Medical Products for:

Leishmaniasis

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Amphotericin B Liposomal
Trade Name
(Manufacturer Name)
AmBisome®
(Astellas Pharma US, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of visceral leishmaniasis.
More Information about this product Drug Information Portal

Generic Name miltefosine
Trade Name
(Manufacturer Name)
Impavido
(Paladin Therapeutics, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of visceral leishmaniasis due to Leishmania donovani; cutaneous leishmaniasis due to Leishmania braziliensis, Leishmania guyanensis, and Leishmania panamensis; and mucosal leishmaniasis due to Leishmania braziliensis.
More Information about this product Drug Information Portal